MedTrace Logo

Blood Glucose Self Monitoring and HbA1c Effects on Glucose Control

NCT00688363 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2011-08-01

No results posted yet for this study

Summary

The purpose of this randomized, prospective trial is to determine wether (a) a once weekly glucose profile (self monitoring) or (b) a three-monthly report of the actual glycated haemoglobin are effective interventions to improve HbA1c after one year in typ 2-diabetic patients on conventional insulin treatment.

Conditions

Interventions

PROCEDURE

weekly blood glucose profile

once daily self-control of urinary-glucose

PROCEDURE

three-monthly haemoglobin A1c

once daily self-control of urinary-glucose

PROCEDURE

no blood-glucose self-control

once daily self-control of urinary-glucose

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Deutsche Diabetes Gesellschaft

    lead OTHER

Principal Investigators

  • Michael A. Nauck, Prof. Dr. · Diabeteszentrum Bad Lauterberg

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-02-28
Primary Completion
2008-09-30
Completion
2008-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00688363 on ClinicalTrials.gov